首页> 外文OA文献 >Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma

【2h】

Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma

机译：糠酸莫米松/富马酸福莫特罗联合应用对COPD或哮喘患者晶状体混浊的评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Maspero Jorge; Cherrez Ivan; Doherty Dennis E.; Tashkin Donald P.; Kuna Piotr; Kuo Wen-Ling; Gates Davis; Nolte Hendrik; Chylack Leo T.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma. [J] . Jorge Maspero, Ivan Cherrez, Dennis E Doherty, Respiratory medicine . 2014,第9期

机译：糠酸莫米松/富马酸福莫特罗联合应用对COPD或哮喘患者晶状体混浊的评估。
2. Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD [J] . Dennis E Doherty, Donald P Tashkin, Edward Kerwin, International Journal of Chronic Obstructive Pulmonary Disease . 2012,第3期

机译：糠酸莫米他松/富马酸福莫特罗固定剂量联合制剂对慢性阻塞性肺疾病（COPD）的影响：一项为期52周的中度至非常重度COPD受试者的III期试验结果
3. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease [J] . Teddy Kosoglou, James Hubbell, Fengjuan Xuan, International Journal of Chronic Obstructive Pulmonary Disease . 2013,第1s期

机译：慢性阻塞性肺疾病患者口服糠酸莫米松/福莫特罗富马酸盐计量吸入器与糠酸莫米松干粉吸入器口服吸入后，糠酸莫米松的全身生物利用度比较
4. IL6 -174G>C and TNFA -308G>A polymorphisms in Bulgarian patients with COPD and Bronchial asthma. [C] . Dimov D, Kurzawski M, Lapczuk J, World Asthma COPD Forum . 2011

机译：IL6 -174G> C和TNFA -308G>保加利亚COPD和支气管哮喘患者的多态性。
5. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease [O] . Teddy Kosoglou, James Hubbell, Fengjuan Xuan, 2013

机译：慢性阻塞性肺疾病患者口服糠酸莫米松/福莫特罗富马酸盐计量吸入器与糠酸莫米松干粉吸入器口服吸入后糠酸莫米松的全身生物利用度比较
6. Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD [O] . Doherty, Dennis E, Tashkin, Donald P, Kerwin, Edward, 2012

机译：糠酸莫米松/富马酸福莫特罗固定剂量联合制剂对慢性阻塞性肺疾病（COPD）的影响：一项为期52周的中度至非常重度COPD受试者的III期试验结果

Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma

著录项

引文网络

相似文献

相关主题

期刊订阅